These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30679930)

  • 21. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia: a case-control study.
    Mengesha MM; Embibel M; Gobena T; Tunje A; Jerene D; Hallström IK
    BMC Pediatr; 2022 Nov; 22(1):653. PubMed ID: 36357856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast.
    Nyongesa MK; Mwatasa MH; Kagonya VA; Mwambingu G; Ngetsa C; Newton CRJC; Abubakar A
    BMC Infect Dis; 2022 May; 22(1):449. PubMed ID: 35545757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study.
    Lukyamuzi Z; Etajak S; Katairo T; Mukunya D; Tetui M; Ssenyonjo A; Wanyenze RK
    BMC Infect Dis; 2021 Nov; 21(1):1168. PubMed ID: 34798852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of unsuppressed viral load among adults on follow up of antiretroviral therapy at selected public and private health facilities of Adama town: unmached case-control study.
    Jaleta F; Bekele B; Kedir S; Hassan J; Getahun A; Ligidi T; Garoma G; Itefa K; Gerenfes T; Botore A; Kenate B; Dagafa G; Muleta D
    BMC Public Health; 2022 Sep; 22(1):1770. PubMed ID: 36123609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to Antiretroviral Therapy by Medication Possession Ratio and Virological Suppression among Adolescents and Young Adults Living with HIV in Dar es Salaam, Tanzania.
    Amour M; Sangeda RZ; Kidenya B; Balandya E; Mmbaga BT; Machumi L; Rugarabamu A; Aris E; Njiro BJ; Ndumwa HP; Lyamuya E; Sunguya BF
    Trop Med Infect Dis; 2022 Mar; 7(4):. PubMed ID: 35448827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern.
    Muri L; Gamell A; Ntamatungiro AJ; Glass TR; Luwanda LB; Battegay M; Furrer H; Hatz C; Tanner M; Felger I; Klimkait T; Letang E;
    AIDS; 2017 Jan; 31(1):61-70. PubMed ID: 27677163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dolutegravir-based drug combinations on the level of medication adherence and viral load among adolescents living with HIV in resource-limited setting: a pre-post design.
    Ezenwosu IL; Onu JU; Chukwuma UV; Onwuka-Kalu C; Omotola OF; Ezenwosu OU; Chukwuka CJ
    Int J Adolesc Med Health; 2023 Dec; 35(6):457-465. PubMed ID: 38059505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.
    Ramadhani HO; Thielman NM; Landman KZ; Ndosi EM; Gao F; Kirchherr JL; Shah R; Shao HJ; Morpeth SC; McNeill JD; Shao JF; Bartlett JA; Crump JA
    Clin Infect Dis; 2007 Dec; 45(11):1492-8. PubMed ID: 17990233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia.
    Waju B; Dube L; Ahmed M; Assefa SS
    HIV AIDS (Auckl); 2021; 13():513-526. PubMed ID: 34017201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and consequences of HIV status disclosure to adolescents living with HIV in Eastern Cape, South Africa: a prospective cohort study.
    Edun O; Shenderovich Y; Zhou S; Toska E; Okell L; Eaton JW; Cluver L
    J Int AIDS Soc; 2022 May; 25(5):e25910. PubMed ID: 35543100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and facilitators to viral load suppression among people living with HIV following intensive adherence counseling in Kampala, Uganda: A qualitative study.
    Izudi J; Cattamanchi A; Castelnuovo B; King R
    Soc Sci Med; 2024 Feb; 343():116595. PubMed ID: 38242033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
    Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
    Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study.
    Arage G; Tessema GA; Kassa H
    BMC Public Health; 2014 Apr; 14():365. PubMed ID: 24735561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.